ArticleNew microbes and new infections2026
A practical nomogram for predicting multidrug-resistant organism infection in a tertiary county-level hospital to guide antimicrobial therapy.
Article in New microbes and new infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prevalence of multidrug-resistant organisms (MDROs) varies geographically, and uniform standards for its management are lacking. Methods: This retrospective single-center study included 1045 unique patients after excluding duplicate isolates from 1304 non-repetitive strains collected between January and December 2023. Multivariable logistic regression was used to identify MDRO predictors and construct a nomogram. Model performance was assessed by ROC curve, calibration curve, and decision curve analysis, with bootstrap internal validation (1000 resamples). A sensitivity analysis excluding ESBL was also performed. Results: Six independent risk factors were identified: age ≥60 years (OR = 1.47), urinary tract infection(UTIs) (OR = 1.79), ESBL production(OR = 15.18), Conclusions: Age ≥60 years, urinary tract infection, ESBL production,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.